D081KC00001: A Phase I/II Study of MEDI4736 (Anti-PD-L1 Antibody) in Combination with Olaparib (PARP inhibitor) in Patients with Advanced Solid Tumors

March 08, 2016
https://clinicaltrials.gov/ct2/show/NCT02734004
Solid Tumors
Principal Investigator: Ding Wang, MD
Advanced Solid Tumors
Accepting Participants
(313)916-1784